Stock Track | ASYMCHEM Plummets 5.16% on Shareholder Transfer and Weak Q1 Earnings

Stock Track04-29 09:34

ASYMCHEM's stock price plummeted 5.16% during intraday trading on Wednesday, marking a significant decline for the pharmaceutical company.

The sharp drop follows the news of a major shareholder transferring a HK$177 million stake, representing 6.06% of the company's holdings, from Citibank to Morgan Stanley Hong Kong Securities. Concurrently, the company released its first-quarter 2026 financial results, which revealed a year-on-year decrease in net profit attributable to shareholders of 6.82%, despite a revenue increase of 16.91%. The adjusted net profit fell by 10.88% compared to the same period last year.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment